Shares of Applied DNA Sciences, Inc. (APDN) are surging more than 18% Wednesday morning after the company established a SARS-CoV-2 mutations and variants tracking program teaming up with Northwell Health.
The companies have entered into a pro bono Material Transfer Agreement (MTA).
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com